Marketing-authorisation holder
Eli Lilly and Company Limited
12 medicines in 2 countries, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder
12 medicines in 2 countries, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| GLUCAGON AMPOULE 666 1MG1 mg / ml · Powder For Solution | Glucagon | Canada | Cancelled | 1961 |
| ILETIN INSULIN REGULAR 100UNIT/ML100 unit / ml · Liquid | Insulin zinc | Canada | Cancelled | 1980 |
| ILETIN LENTE INSULIN INJ 100UNIT/ML100 unit / ml · Suspension (Lente) | Insulin zinc | Canada | Cancelled | 1980 |
| ILETIN NPH INSULIN 100UNIT/ML100 unit / ml · Liquid | Insulin (human) | Canada | Cancelled | 1980 |
| LENTE PURIFIED PORK INSULIN INJ100 unit / ml · Suspension (Lente) | Insulin (human) | Canada | Cancelled | 1980 |
| Liprolog | Insulin lispro | EU (EMA) | Withdrawn | 1997 |
| Meloxivet | Meloxicam | EU (EMA) | Withdrawn | 2007 |
| NPH PURIFIED PORK INSULIN INJ100 unit / ml · Liquid | Insulin (human) | Canada | Cancelled | 1980 |
| Olansek | Olanzapine | EU (EMA) | Withdrawn | 1996 |
| Recuvyra | Fentanyl | EU (EMA) | Cancelled | 2011 |
| REGULAR PURIFIED PORK INSULIN INJ100 unit / ml · Liquid | Insulin (human) | Canada | Cancelled | 1980 |
| Trifexis | Spinosad, Milbemycin oxime | EU (EMA) | Cancelled | 2013 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 7 | 0 | 7 | CompaniesAll medicines |
| European Union (EMA) | 5 | 0 | 5 | CompaniesAll medicines |
Also in the registers of Italy
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.